Clinical Trials Logo
  1. Home
  2. Joint Pain
  3. NCT03209895

Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain

Joint Pain Clinical Trial

Official title:
A Double-Blinded, Placebo Controlled, Human Clinical Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain

Clinical Trial Summary

This study is designed to evaluate the effectiveness of a proprietary nutritional supplement that contains Krill Oil (KO), astaxanthin (AX) and hyaluronic acid (HA) to reduce pain and discomfort in participants, compared to an inert placebo (palm oil) control and to a positive control (glucosamine-chondroitin). The purpose of the study is to determine if the combination of KO, AX, and HA will benefit participants with joint pain.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03209895
Study type Interventional
Source U.S. Nutraceuticals, LLC
Contact
Status Completed
Phase N/A
Start date October 8, 2010
Completion date June 13, 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT05052112 - Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Completed NCT04506411 - Turmeric Efficacy for Mobility and Joint Function N/A
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Completed NCT04408560 - Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer N/A
Completed NCT04150211 - Effects of Exten(d) Supplementation on Training Ability in Recreational Runners Phase 2
Withdrawn NCT01612728 - Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Phase 2
Completed NCT00691678 - Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer Phase 2
Recruiting NCT05212259 - Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects N/A
Recruiting NCT04182659 - Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms N/A
Terminated NCT04712019 - Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA N/A
Recruiting NCT06074744 - Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty N/A
Recruiting NCT00325845 - Synvisc Injections for Lumbar Facet Joint Pain Phase 3
Terminated NCT04872556 - Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients N/A
Active, not recruiting NCT03865992 - Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease N/A
Recruiting NCT05282992 - NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort N/A
Recruiting NCT04994249 - Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
Completed NCT01509079 - Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors Phase 2
Completed NCT04764110 - Short-term Impact of Cyplexinol® on Self-reported Joint Pain N/A
Not yet recruiting NCT06444867 - A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 Phase 1